CAMBRIDGE, Mass., Feb. 15, 2011 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR), an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced the appointment of Diane L. Tribble, Ph.D., M.M.Sc. to its executive team as Chief Scientific Officer.
